NCT05244902

Brief Summary

In the recent literature, pre-operative fasting times for pediatric patients are limited to one hour for clear fluids. Studies related to gastric emptying times mostly searched for normal-weight children. These studies have claimed that 3 mL/kg clear fluid can be allowed up to 1 hour before surgery. There is a lack of interest in the gastric emptying time of obese pediatric patients during the preoperative period. In addition, there is controversy about gastric emptying times of obese healthy children. Some research committed the decrease of gastric emptying because of a high level of sensitivity to cholecystokinin, while others postulated that no change in gastric emptying time of obese children compared to normal weight. The aim of this trial is to compare the gastric volume and gastric emptying time after ingestion of 3 mL/kg clear fluid in obese and non-obese pediatric patients in the pre-operative period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 8, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

March 10, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 17, 2022

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

5 months

First QC Date

February 8, 2022

Last Update Submit

November 23, 2022

Conditions

Keywords

Gastric volumeGastric emptying timeAntral cross-sectional area (ACSA)Obese pediatric patients

Outcome Measures

Primary Outcomes (1)

  • Gastric emptying time

    Time until the gastric volume reaches the baseline level again.

    90 minute

Secondary Outcomes (1)

  • Antral cross-sectional area

    90 minute

Other Outcomes (2)

  • Gastric emptying half-time ( t 1/2)

    90 minute

  • Gastric volume

    90 minute

Study Arms (2)

Obese pediatric patient

EXPERIMENTAL

Obese children aged 6-14 years, over 95% percentile, fasted for the night before planned surgery.

Drug: 5% Dextrose

Non-obese pediatric patient

ACTIVE COMPARATOR

Non-obese children aged 6-14 years, between 5-85% percentile, fasted for the night before planned surgery.

Drug: 5% Dextrose

Interventions

All the patients will receive oral 3mL/kg 5%Dextrose

Non-obese pediatric patientObese pediatric patient

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASA physical state I or II
  • Age 6 to 14 years.
  • Gender: both sexes.
  • Scheduled for non-Gastrointestinal Tract elective day-case surgery under general anesthesia.

You may not qualify if:

  • Parent/ care giver refusal
  • Ages \< 6 or \> 14 years old
  • Children with gastro-esophageal reflux disease
  • Renal failure
  • Diabetes mellitus
  • Cerebral palsy patients
  • Mental retardation
  • Esophageal strictures, achalasia or any intestinal disease that may impair the gastric emptying.
  • Gastrointestinal system surgery and neurosurgical patients
  • Emergency surgery
  • Violation of the prescribed fasting times
  • Refusing to drink prescribed clear fluid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karaman Taining and Research Hospital

Karaman, 70200, Turkey (Türkiye)

Location

MeSH Terms

Interventions

Glucose

Intervention Hierarchy (Ancestors)

HexosesMonosaccharidesSugarsCarbohydrates

Study Officials

  • Muhammet Korkusuz, MD

    Karaman Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pediatric patients will be divided into two groups as obese and non-obese. Children above the 95% percentile will be considered as obese.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator, MD

Study Record Dates

First Submitted

February 8, 2022

First Posted

February 17, 2022

Study Start

March 10, 2022

Primary Completion

August 17, 2022

Study Completion

August 17, 2022

Last Updated

November 25, 2022

Record last verified: 2022-11

Locations